Cytotoxicity with Auger electron-emitting radionuclides delivered by antibodies

International Journal of Cancer

Volumn 81, Issue 6, 1999, Pages 985-992

  Griffiths, Gary L ^a   Govindan, Serengulam V ^a   Sgouros, George ^b   Ong, Gaik Lin ^c   Goldenberg, David M ^c   Mattes, M Jules ^c,d  

^a IMMUNOMEDICS INC   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c Gdn Stt Cancer Ctr Ctr Molec M   (United States)

^d GARDEN STATE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; INDIUM 111; IODINE 125; RADIOISOTOPE; TECHNETIUM 99M;

ARTICLE; AUGER ELECTRON SPECTROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOMA CELL LINE; LYSOSOME; PRIORITY JOURNAL; RADIOISOTOPE DISTRIBUTION; RADIOISOTOPE THERAPY;

ANTIBODIES; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; ANTIGENS, NEOPLASM; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; ELECTRONS; GAMMA RAYS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INDIUM RADIOISOTOPES; IODINE RADIOISOTOPES; KINETICS; LYMPHOMA, B-CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; RADIOIMMUNOTHERAPY; TECHNETIUM; TUMOR CELLS, CULTURED;

EID: 0033005510     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990611)81:6<985::AID-IJC23>3.0.CO;2-W     Document Type: Article

References (27)

1. BARRY, M.A., BEHNKE, C.A. and EASTMAN, A., Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem. Pharmacol., 40, 2353-2362 (1990).
2. 125I-labeled monoclonal antibody 425 to epidermal growth factor receptor. Cancer Res., 52, 121-126 (1992).
3. CHERNEY, B.S., BHATIA, K.G., SGADARI, C., GUITIERREZ, M.I., MOSTOWSKI, H., PIKE, S.E., GUPTA, G., MAGRATH, I.T. and TOSATO, G., Role of the p53 tumor suppressor gene in the tumorigenicity of Burkitt's lymphoma cells. Cancer Res., 57, 2508-2515 (1997).
4. DAGHIGHIAN, F., BARENDSWAARD, E., WELT, S., HUMM, J., SCOTT, A., WILLINGHAM, M.C., MCGUFFIE, E., OLD, L.J. and LARSON, S.M., Enhancement of radiation dose to the nucleus by vesicular internalization of iodine-125-labeled A33 monoclonal antibody. J. nucl. Med., 37, 1052-1057 (1996).
5. 131I-Lym-1 as a model. Cancer, 73, 1038 (1994).
6. GODDU, S.M., HOWELL, R.W., BOUCHET, L.G., BOLCH, W.E. AND RAO, D.V., MIRD cellular S values, Society of Nuclear Medicine, Reston, VA (1997).
7. GODDU, S.M., RAO, D.V. and HOWELL, R.W., Multicellular dosimetry for micrometastases: dependence of self-dose versus cross-dose to cell nuclei on type and energy of radiation and subcellular distribution of radionuclides. J. nucl. Med., 35, 521-530 (1994).
8. GOVINDAN, S.V., MATTES, M.J., STEIN, R., MCBRIDE, B.J., KARACAY, H., GOLDENBERG, D.M., HANSEN, H.J. and GRIFFITHS, G.L., Labeling of monoclonal antibodies with DTPA-appended radioiodinated peptides containing D-amino acids). Bioconjugate them., 10, 231-240 (1999).
9. HANSEN, H.J., ONG, G.L., DIRIL, H., ROCHE, P.A., GRIFFITHS, G.L., GOLDENBERG, D.M. and MATTES, M.J., Internalization and catabolism of radiolabeled antibodies to the MHC class Il invariant chain by B-cell lympnomas. Biochem. J., 320, 293-300 (1996).
10. HORAK, E., HARTMANN, F., GARMESTANI, K., WU, C., BRECHBIEL, M., GANSOW, O.A., LANDOLFI, N.F. and WALDMANN, T.A., Radioimmunotherapy targeting of HER2/neu oncoprotein on ovarian tumor using lead-212-DOTA-AE1. J. nucl. Med., 38, 1944-1950 (1997).
11. HOWELL, R.W., Radiation spectra for Auger-electron emitting radionuclides: report No. 2 of AAPM nuclear medicine task group No. 6. Med. Phys., 19, 1371-1383 (1992).
12. JONKHOFF, A.R., HUIJGENS, P., VERSTEEGH, R.T., VAN DIEREN, E.B., OSSENKOPPELE, G.J., MARTENS, H.J.M. and TEULE, G.J.J., Gallium-67 radiotoxicity in human U937 lymphoma cells. Brit. J. Cancer, 67, 693-700 (1993).
13. KARACAY, H., ONG, G.L., HANSEN, H.J., GRIFFITHS, G.L., GOLDENBERG, D.M. and MATTES, M., Intracellular processing of technetium-99m-antibody conjugates. Nucl. Med. Comm., 19, 971-979 (1998).
14. 125I in mammalian cells. Rad. Res., 111, 305-318 (1987).
15. KOZAK, R.W., ATCHER, R.W., GANSOW, O.A., FRIEDMAN, A.M., HINES, J.J. and WALDMANN, T.A., Bismuth-212-labeled anti-TAC monoclonal antibody: α-particle-emitting radionuclides as modalities for radioimmunotherapy. Proc. nat. Acad. Sci. (Wash.), 83, 474-478 (1986).
16. KYRIAKOS, R.J., SHIH, L.B., ONG, G.L., PATEL, K., GOLDENBERG, D.M. and MATTES, M.J., The fate of antibodies bound to the surface of tumor cells in vitro. Cancer Res., 52, 835-842 (1992).
17. LITTLE, J.B. and WILLIAMS, J.R., Effects of ionizing radiation on mammalian cells. In: D.H.K. Lee, H.L. Falk, S.D. Murphy and S.R. Geiger (eds.), Handbook of physiology, sect. 9, pp. 127-155, American Physiological Society, Bethesda, MD (1977).
18. 111In-pentetreotide: initial observations and future directions. Cancer J. Sci. Amer., 4, 94-102 (1998).
19. O'CONNOR, P.M., JACKMAN, M.J., JONDLE, D., BHATIA, K., MAGRATH, I. and KOHN, K.W., Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines. Cancer Res., 53, 4776-4780 (1993).
20. O'DONOGHUE, J.A., BARDIES, M. and WHELDON, T.E., Relationships between tumor size and curability for uniformly targeted therapy with beta-emitting radionuclides. J. nucl. Med., 36, 1902-1909 (1995).
21. PFIZENMAIER, K., SCHEURICH, P., SCHLUTER, C. and KRONKE, M., Tumor necrosis factor enhances HLA-A,B,C and HLA-DR gene expression in human tumor cells. J. Immunol., 138, 975-980 (1987).
22. SASTRY, K.S.R., HAYDOCK, C., BASHA, A.M. and RAO, D.V., Electron dosimetry for radioimmunotherapy: optimal electron energy. Rad. Protect. Dosimetry, 13, 249-252 (1985).
23. SHIH, L.B., THORPE, S.R., GRIFFITHS, G.L., DIRIL, H., ONG, G.L., HANSEN, H.J., GOLDENBERG, D.M. and MATTES, M.J., The processing and fate of antibodies and their radiolabels bound to the surface of tumor cells in vitro: a comparison of nine radiolabels. J. nucl. Med., 35, 899-908 (1994).
24. 125I-labeled anti-gp160 monoclonal antibody. Cancer Res., 48, 2768-2773 (1988).
25. THAKUR, M.L. and MCAFEE, J.G., The significance of chromosomal aberrations in indium-111 labeled lymphocytes. J. nucl. Med., 25, 922-927 (1984).
26. WARTERS, R.L., HOFER, K.G., HARRIS, C.R. and SMITH, J.M., Radionuclide toxicity in cultured mammalian cells: elucidation of the primary site of radiation damage. Curr. Topics Rad. Res. Quart., 12, 389 (1977).
27. 125I-labeled monoclonal antibody 17-1a in human cancer cells. Cancer Res., 49, 2952-2958 (1989).